Venture Life Group (LON:VLG) Issues Quarterly Earnings Results

Venture Life Group (LON:VLG) issued its earnings results on Tuesday. The company reported GBX 4.10 earnings per share for the quarter, Digital Look Earnings reports. Venture Life Group had a return on equity of 7.82% and a net margin of 17.42%.

Venture Life Group Trading Up 1.3%

Shares of Venture Life Group stock traded up GBX 0.91 during trading on Friday, hitting GBX 69.41. The stock had a trading volume of 1,062,059 shares, compared to its average volume of 281,785. The stock has a 50 day simple moving average of GBX 67.38 and a 200 day simple moving average of GBX 65.11. Venture Life Group has a 1 year low of GBX 52 and a 1 year high of GBX 72. The company has a quick ratio of 1.48, a current ratio of 4.71 and a debt-to-equity ratio of 0.82. The company has a market capitalization of £83.33 million, a PE ratio of 15.88, a P/E/G ratio of 5.67 and a beta of 0.23.

Insider Transactions at Venture Life Group

In related news, insider Daniel Wells acquired 14,760 shares of the stock in a transaction dated Thursday, October 1st. The shares were acquired at an average price of GBX 68 per share, with a total value of £10,036.80. Insiders own 7.52% of the company’s stock.

About Venture Life Group

Venture Life is an international consumer self-care company focused on developing and commercialising products for the global self-care market helping our consumers live a longer healthier and more rewarding life.

Headquartered in the UK, the Group’s product portfolio includes Balance Activ in the area of women’s intimate healthcare, Earol® supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, plus the Health & Her product range supporting the hormonal lifecycle.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through health & beauty stores, pharmacies, grocery multiples and e-commerce channels and are sold globally.